Concepts (342)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 26 | 2022 | 336 | 4.500 |
Why?
|
| Thrombosis | 20 | 2023 | 545 | 3.310 |
Why?
|
| Venules | 9 | 2022 | 29 | 1.940 |
Why?
|
| Neutrophils | 9 | 2021 | 362 | 1.510 |
Why?
|
| von Willebrand Factor | 6 | 2024 | 205 | 1.430 |
Why?
|
| Histones | 3 | 2022 | 572 | 1.280 |
Why?
|
| von Willebrand Diseases | 2 | 2022 | 55 | 1.210 |
Why?
|
| Cornea | 10 | 2024 | 599 | 1.120 |
Why?
|
| Endotoxemia | 4 | 2012 | 55 | 1.030 |
Why?
|
| Fluorescent Dyes | 5 | 2018 | 270 | 1.030 |
Why?
|
| Epithelium, Corneal | 8 | 2024 | 169 | 0.970 |
Why?
|
| Microcirculation | 6 | 2021 | 115 | 0.930 |
Why?
|
| Capillary Permeability | 9 | 2005 | 77 | 0.890 |
Why?
|
| Endothelium, Vascular | 7 | 2020 | 504 | 0.860 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2022 | 145 | 0.840 |
Why?
|
| Corneal Injuries | 6 | 2023 | 36 | 0.800 |
Why?
|
| Vasculitis | 2 | 2021 | 49 | 0.800 |
Why?
|
| Platelet Aggregation | 9 | 2016 | 120 | 0.780 |
Why?
|
| CD18 Antigens | 2 | 2021 | 43 | 0.770 |
Why?
|
| P-Selectin | 7 | 2015 | 74 | 0.760 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 10 | 0.730 |
Why?
|
| Hyperemia | 1 | 2021 | 35 | 0.720 |
Why?
|
| Cell Degranulation | 1 | 2021 | 28 | 0.720 |
Why?
|
| Nitric Oxide Synthase | 5 | 2007 | 177 | 0.710 |
Why?
|
| Erythrocytes | 2 | 2021 | 232 | 0.710 |
Why?
|
| Mast Cells | 1 | 2021 | 71 | 0.700 |
Why?
|
| Animals | 55 | 2025 | 36222 | 0.680 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2024 | 140 | 0.650 |
Why?
|
| Mice | 39 | 2025 | 18936 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 22 | 2024 | 4823 | 0.590 |
Why?
|
| Intravital Microscopy | 1 | 2018 | 19 | 0.580 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 616 | 0.560 |
Why?
|
| Microvessels | 2 | 2020 | 62 | 0.540 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2025 | 558 | 0.530 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2002 | 61 | 0.520 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 301 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 306 | 0.510 |
Why?
|
| Platelet Activation | 5 | 2020 | 71 | 0.490 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2015 | 2 | 0.490 |
Why?
|
| Neutrophil Activation | 2 | 2005 | 12 | 0.490 |
Why?
|
| Antithrombin III | 1 | 2015 | 28 | 0.480 |
Why?
|
| Nitric Oxide | 3 | 2007 | 487 | 0.460 |
Why?
|
| Sepsis | 3 | 2010 | 522 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 385 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 395 | 0.450 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 149 | 0.450 |
Why?
|
| Wound Healing | 8 | 2021 | 483 | 0.450 |
Why?
|
| Diet, High-Fat | 5 | 2024 | 241 | 0.440 |
Why?
|
| Acetaminophen | 1 | 2015 | 102 | 0.440 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 125 | 0.440 |
Why?
|
| Inflammation | 6 | 2022 | 1570 | 0.430 |
Why?
|
| Hepatocytes | 1 | 2015 | 245 | 0.430 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2023 | 65 | 0.430 |
Why?
|
| Serum Albumin | 1 | 2013 | 115 | 0.400 |
Why?
|
| Fibrin | 4 | 2024 | 64 | 0.370 |
Why?
|
| Obesity | 6 | 2024 | 2445 | 0.350 |
Why?
|
| Collagen | 4 | 2023 | 314 | 0.340 |
Why?
|
| Muscle, Skeletal | 3 | 2005 | 1041 | 0.310 |
Why?
|
| Hemostasis | 3 | 2019 | 72 | 0.310 |
Why?
|
| Enzyme Inhibitors | 3 | 2002 | 606 | 0.300 |
Why?
|
| Cell Movement | 6 | 2021 | 906 | 0.290 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 431 | 0.290 |
Why?
|
| Serum Albumin, Bovine | 4 | 2003 | 56 | 0.280 |
Why?
|
| Electromagnetic Fields | 1 | 2007 | 27 | 0.280 |
Why?
|
| Mice, Knockout | 13 | 2019 | 3979 | 0.280 |
Why?
|
| Capillaries | 2 | 2005 | 70 | 0.270 |
Why?
|
| Cell Communication | 2 | 2005 | 190 | 0.270 |
Why?
|
| Endothelial Cells | 1 | 2010 | 539 | 0.270 |
Why?
|
| Dyslipidemias | 2 | 2020 | 246 | 0.260 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2007 | 74 | 0.260 |
Why?
|
| Edema | 1 | 2007 | 148 | 0.260 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 247 | 0.250 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 450 | 0.240 |
Why?
|
| Mitochondria, Muscle | 1 | 2005 | 39 | 0.240 |
Why?
|
| Male | 28 | 2024 | 65939 | 0.240 |
Why?
|
| Endotoxins | 1 | 2005 | 49 | 0.240 |
Why?
|
| Rats | 8 | 2007 | 3851 | 0.240 |
Why?
|
| Mesentery | 2 | 2002 | 27 | 0.240 |
Why?
|
| Albumins | 2 | 2002 | 99 | 0.240 |
Why?
|
| Arterioles | 1 | 2005 | 30 | 0.240 |
Why?
|
| Muscle Contraction | 1 | 2005 | 166 | 0.230 |
Why?
|
| Oculomotor Muscles | 1 | 2005 | 68 | 0.230 |
Why?
|
| Phagocytosis | 3 | 2024 | 194 | 0.230 |
Why?
|
| Megakaryocytes | 1 | 2025 | 45 | 0.230 |
Why?
|
| omega-N-Methylarginine | 2 | 2002 | 12 | 0.230 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 240 | 0.220 |
Why?
|
| Calcium | 2 | 2007 | 1100 | 0.220 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 4760 | 0.220 |
Why?
|
| Cardiolipins | 1 | 2024 | 19 | 0.210 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 186 | 0.210 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 173 | 0.210 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2024 | 27 | 0.210 |
Why?
|
| Leukocytes | 4 | 2020 | 216 | 0.210 |
Why?
|
| Secretory Vesicles | 3 | 2019 | 21 | 0.210 |
Why?
|
| Corneal Stroma | 1 | 2024 | 80 | 0.210 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 160 | 0.210 |
Why?
|
| Pandemics | 2 | 2022 | 1193 | 0.210 |
Why?
|
| Models, Animal | 2 | 2021 | 483 | 0.200 |
Why?
|
| Lipopolysaccharides | 3 | 2012 | 316 | 0.200 |
Why?
|
| Light | 2 | 2004 | 183 | 0.200 |
Why?
|
| Sucrose | 1 | 2023 | 43 | 0.200 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2022 | 43 | 0.190 |
Why?
|
| Hemostatics | 1 | 2022 | 62 | 0.190 |
Why?
|
| Humans | 26 | 2024 | 133811 | 0.190 |
Why?
|
| Exocytosis | 2 | 2019 | 66 | 0.180 |
Why?
|
| Fluorescein-5-isothiocyanate | 4 | 2003 | 29 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2005 | 1303 | 0.180 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 115 | 0.180 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2021 | 57 | 0.180 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 353 | 0.170 |
Why?
|
| Meibomian Glands | 1 | 2020 | 44 | 0.170 |
Why?
|
| Hypertrophy | 1 | 2020 | 102 | 0.170 |
Why?
|
| Macrophages | 2 | 2024 | 697 | 0.170 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 2011 | 130 | 0.170 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2020 | 67 | 0.160 |
Why?
|
| Face | 1 | 2021 | 190 | 0.160 |
Why?
|
| Splanchnic Circulation | 4 | 2002 | 52 | 0.160 |
Why?
|
| Catalytic Domain | 3 | 2023 | 181 | 0.150 |
Why?
|
| Tears | 1 | 2020 | 176 | 0.150 |
Why?
|
| Munc18 Proteins | 1 | 2019 | 20 | 0.150 |
Why?
|
| Regeneration | 1 | 2021 | 228 | 0.150 |
Why?
|
| Ischemia | 1 | 2002 | 382 | 0.150 |
Why?
|
| Phosphatidylserines | 3 | 2013 | 49 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2020 | 242 | 0.140 |
Why?
|
| Fibrinogen | 4 | 2023 | 163 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 365 | 0.140 |
Why?
|
| Cytokines | 2 | 2015 | 1381 | 0.140 |
Why?
|
| Staining and Labeling | 1 | 2018 | 176 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2025 | 2029 | 0.140 |
Why?
|
| Proteins | 1 | 2003 | 1099 | 0.140 |
Why?
|
| Actins | 2 | 2016 | 346 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 2 | 2023 | 55 | 0.130 |
Why?
|
| Antibodies | 1 | 2018 | 372 | 0.130 |
Why?
|
| Thrombin | 3 | 2013 | 62 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2021 | 731 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2018 | 195 | 0.120 |
Why?
|
| Platelet Function Tests | 2 | 2013 | 41 | 0.120 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 11 | 0.120 |
Why?
|
| Corneal Keratocytes | 1 | 2015 | 5 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2011 | 32 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 85 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 43 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 132 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2015 | 72 | 0.110 |
Why?
|
| Conscious Sedation | 1 | 2015 | 62 | 0.110 |
Why?
|
| Gene Expression | 2 | 2012 | 1611 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 289 | 0.110 |
Why?
|
| Platelet Storage Pool Deficiency | 1 | 1994 | 2 | 0.110 |
Why?
|
| Calcineurin | 1 | 2014 | 100 | 0.110 |
Why?
|
| Anesthesia, General | 1 | 2015 | 124 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 51 | 0.100 |
Why?
|
| Blood Coagulation | 2 | 2016 | 134 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2015 | 395 | 0.100 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1994 | 156 | 0.090 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 29 | 0.090 |
Why?
|
| Diet | 1 | 2019 | 1191 | 0.090 |
Why?
|
| Xanthenes | 2 | 2002 | 7 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2014 | 4922 | 0.090 |
Why?
|
| Research Design | 2 | 2007 | 757 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 2010 | 67 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 230 | 0.090 |
Why?
|
| Heart Valve Prosthesis | 1 | 1994 | 313 | 0.080 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 63 | 0.080 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 85 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2011 | 130 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 231 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1618 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2012 | 3144 | 0.080 |
Why?
|
| Rana pipiens | 2 | 2002 | 38 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 1770 | 0.080 |
Why?
|
| Neurons | 1 | 2019 | 2050 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 966 | 0.080 |
Why?
|
| Time Factors | 3 | 2021 | 6554 | 0.080 |
Why?
|
| Complement C3 | 1 | 2009 | 54 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2023 | 432 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2008 | 117 | 0.070 |
Why?
|
| Arginine | 3 | 2005 | 350 | 0.070 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2008 | 8 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 444 | 0.070 |
Why?
|
| Perfusion | 2 | 2002 | 210 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2008 | 52 | 0.070 |
Why?
|
| Carrageenan | 1 | 2007 | 6 | 0.070 |
Why?
|
| Platelet Adhesiveness | 1 | 2008 | 40 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2021 | 509 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 74 | 0.070 |
Why?
|
| Swine | 2 | 2002 | 1205 | 0.070 |
Why?
|
| Shear Strength | 1 | 2007 | 17 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 53 | 0.070 |
Why?
|
| Histamine | 1 | 2007 | 49 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 317 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1733 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2011 | 932 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2010 | 289 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1075 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 211 | 0.060 |
Why?
|
| Chlorophenols | 1 | 2005 | 1 | 0.060 |
Why?
|
| Calcimycin | 1 | 2005 | 21 | 0.060 |
Why?
|
| Citrate (si)-Synthase | 1 | 2005 | 19 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2005 | 41 | 0.060 |
Why?
|
| Keratitis | 1 | 2006 | 110 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2008 | 483 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 1 | 2005 | 37 | 0.060 |
Why?
|
| Heparin | 1 | 2007 | 230 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 93 | 0.060 |
Why?
|
| Caffeine | 1 | 2005 | 70 | 0.060 |
Why?
|
| Female | 7 | 2021 | 71840 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2005 | 148 | 0.060 |
Why?
|
| von Willebrand Disease, Type 3 | 1 | 2024 | 6 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2007 | 710 | 0.050 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2024 | 11 | 0.050 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2024 | 20 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2004 | 73 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 176 | 0.050 |
Why?
|
| Isoelectric Point | 1 | 2003 | 18 | 0.050 |
Why?
|
| Lactalbumin | 1 | 2003 | 11 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 22 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2025 | 366 | 0.050 |
Why?
|
| Adult | 4 | 2015 | 31823 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2003 | 384 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2022 | 86 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1329 | 0.050 |
Why?
|
| Lymph | 1 | 2002 | 7 | 0.050 |
Why?
|
| Mineral Oil | 1 | 2002 | 4 | 0.050 |
Why?
|
| Emollients | 1 | 2002 | 2 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 70 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 107 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2007 | 628 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2021 | 48 | 0.050 |
Why?
|
| Biological Transport | 1 | 2002 | 367 | 0.050 |
Why?
|
| Intra-Abdominal Fat | 1 | 2021 | 59 | 0.050 |
Why?
|
| Species Specificity | 1 | 2002 | 563 | 0.040 |
Why?
|
| Research | 1 | 2003 | 272 | 0.040 |
Why?
|
| Binding Sites | 1 | 2024 | 1379 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2014 | 824 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2020 | 15 | 0.040 |
Why?
|
| Cholesterol Esters | 1 | 2020 | 16 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 75 | 0.040 |
Why?
|
| Bradykinin | 1 | 2000 | 49 | 0.040 |
Why?
|
| Anura | 1 | 2000 | 23 | 0.040 |
Why?
|
| Ceramides | 1 | 2020 | 46 | 0.040 |
Why?
|
| Cicatrix | 1 | 2021 | 124 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 304 | 0.040 |
Why?
|
| Epididymis | 1 | 2020 | 67 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 160 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2015 | 6602 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2000 | 217 | 0.040 |
Why?
|
| Neoplasms | 1 | 2015 | 3035 | 0.040 |
Why?
|
| Photochemistry | 1 | 1999 | 22 | 0.040 |
Why?
|
| Cell Fusion | 1 | 2019 | 38 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2014 | 1707 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2014 | 817 | 0.040 |
Why?
|
| Histidine | 1 | 1999 | 75 | 0.040 |
Why?
|
| Arteries | 1 | 2000 | 228 | 0.040 |
Why?
|
| Hemolysis | 1 | 1999 | 114 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2885 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 3107 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2025 | 1146 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 397 | 0.040 |
Why?
|
| Critical Illness | 1 | 2022 | 629 | 0.040 |
Why?
|
| Triglycerides | 1 | 2020 | 616 | 0.030 |
Why?
|
| Body Composition | 1 | 2020 | 564 | 0.030 |
Why?
|
| Talin | 1 | 2016 | 11 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 396 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 1283 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 320 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 748 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 432 | 0.030 |
Why?
|
| Heart | 1 | 2000 | 712 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 1728 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2005 | 2730 | 0.030 |
Why?
|
| Endosonography | 1 | 2015 | 81 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2014 | 41 | 0.030 |
Why?
|
| Chlorides | 1 | 2014 | 108 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 121 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cofilin 1 | 1 | 2013 | 12 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 144 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 340 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 86 | 0.030 |
Why?
|
| Syk Kinase | 1 | 2012 | 18 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 28 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 250 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1996 | 407 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2015 | 810 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1996 | 389 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 234 | 0.020 |
Why?
|
| Endocytosis | 1 | 2012 | 134 | 0.020 |
Why?
|
| Middle Aged | 2 | 2015 | 29287 | 0.020 |
Why?
|
| Vasodilation | 2 | 2005 | 180 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 441 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 334 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2009 | 14 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 42 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 64 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 594 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2153 | 0.020 |
Why?
|
| Surface Properties | 1 | 2010 | 96 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 66 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 148 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2009 | 8 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 230 | 0.020 |
Why?
|
| Phenanthrenes | 1 | 2008 | 5 | 0.020 |
Why?
|
| Maleimides | 1 | 2008 | 11 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 842 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2524 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2008 | 34 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2008 | 67 | 0.020 |
Why?
|
| Milk Proteins | 1 | 2008 | 92 | 0.020 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2008 | 9 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3422 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 26 | 0.020 |
Why?
|
| CD11a Antigen | 1 | 2007 | 13 | 0.020 |
Why?
|
| Spleen | 1 | 2008 | 287 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 31 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 513 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 103 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 357 | 0.020 |
Why?
|
| Pterins | 1 | 2005 | 6 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2005 | 14 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 334 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 49 | 0.020 |
Why?
|
| Homocysteine | 1 | 2005 | 120 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 180 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 197 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2012 | 1002 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 4593 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2006 | 237 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 258 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1532 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 640 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 7195 | 0.010 |
Why?
|
| Antioxidants | 1 | 2005 | 371 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1933 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 542 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 21714 | 0.010 |
Why?
|
| Ascites | 1 | 1996 | 110 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1996 | 122 | 0.010 |
Why?
|
| Hypoxia | 1 | 1996 | 267 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1996 | 276 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 1175 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1996 | 474 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1996 | 948 | 0.000 |
Why?
|